African Trypanosomiasis
The DNDi Project of the Year - the Development of Fexinidazole to Treat Sleeping Sickness: Accelera recognised as key partner in the development of a new therapy
Published in TB and Outbreaks Week, July 15th, 2008
The development of fexinidazole for the treatment of African trypanosomiasis, commonly known as "sleeping sickness", by DNDi (Drugs for Neglected Diseases initiative), along with Accelera, a business unit of Nerviano Medical Sciences (NMS), is to be honoured as one of DNDi's Success Stories of the Year. The award will be conferred today in New York, at the prestigious headquarters of the New York Academy of Sciences, during the first annual Stakeholders' Meeting of DNDi. Accelera is recognised as DNDi's key partner in the non-clinical development of fexinidazole.
"We are proud to receive this recognition," comments Dr. Marco Brughera – Vice President of Accelera – "and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- American Psychological Association
New 'everyday cognition' scale tracks how older adults function in daily life - La Jolla Institute for Allergy and Immunology
LIAI researchers discover new cellular mechanism that will significantly advance vaccine development - Society for General Microbiology
Mimic molecules to protect against plague - Society for General Microbiology
Potential treatment for TB solves puzzle - University of California - Santa Cruz
Higher temperatures helped new strain of West Nile virus spread - University of Pennsylvania School of Medicine
Penn animal study identifies new DNA weapon against avian flu - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
